A novel multicomponent messenger RNA (mRNA) vaccine, mRNA-1083, demonstrated noninferiority to standard influenza and COVID-19 vaccines in adults aged 50 years or older, eliciting higher immune ...
The world’s first combination seasonal influenza and COVID-19 vaccine, Moderna’s mCombriax, has received marketing ...
COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...
(CNN) — The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat that hasn’t been achieved for the past 45: the development of a ...
A new single-shot combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a phase 3 clinical trial published May 7 in JAMA. The study ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
This week, the European Commission authorized Moderna to market the vaccine, mRNA-1083 or mCOMBRIAX, making it the world’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results